rs750077647
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000297.4(PKD2):βc.302_307delβ(p.Glu101_Glu102del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000178 in 1,516,060 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.0000066 ( 0 hom., cov: 32)
Exomes π: 0.000019 ( 0 hom. )
Consequence
PKD2
NM_000297.4 inframe_deletion
NM_000297.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.02
Genes affected
PKD2 (HGNC:9009): (polycystin 2, transient receptor potential cation channel) This gene encodes a member of the polycystin protein family. The encoded protein is a multi-pass membrane protein that functions as a calcium permeable cation channel, and is involved in calcium transport and calcium signaling in renal epithelial cells. This protein interacts with polycystin 1, and they may be partners in a common signaling cascade involved in tubular morphogenesis. Mutations in this gene are associated with autosomal dominant polycystic kidney disease type 2. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 26 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD2 | NM_000297.4 | c.302_307del | p.Glu101_Glu102del | inframe_deletion | 1/15 | ENST00000237596.7 | NP_000288.1 | |
PKD2 | XM_011532028.3 | c.302_307del | p.Glu101_Glu102del | inframe_deletion | 1/14 | XP_011530330.1 | ||
PKD2 | NR_156488.2 | n.401_406del | non_coding_transcript_exon_variant | 1/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD2 | ENST00000237596.7 | c.302_307del | p.Glu101_Glu102del | inframe_deletion | 1/15 | 1 | NM_000297.4 | ENSP00000237596 | P1 | |
ENST00000662475.1 | n.112+339_112+344del | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00000664 AC: 1AN: 150528Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
150528
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000190 AC: 26AN: 1365532Hom.: 0 AF XY: 0.0000193 AC XY: 13AN XY: 673648
GnomAD4 exome
AF:
AC:
26
AN:
1365532
Hom.:
AF XY:
AC XY:
13
AN XY:
673648
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000664 AC: 1AN: 150528Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73458
GnomAD4 genome
AF:
AC:
1
AN:
150528
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
73458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 20, 2021 | In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; In-frame deletion of 2 amino acids with an unclear effect on protein function - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at